Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Abbott’s Interferon-free Hep C Combo With Ribavirin Has High Cure Rates

This article was originally published in The Pink Sheet Daily

Executive Summary

Abbott revealed more data from its Phase II Aviator program Nov. 10 during a press conference at the American Association for the Study of Liver Disease meeting showing high cure rates in some difficult patient populations and a 100% cure rate for the easier to treat genotype 1 subgroup.


Related Content

As AbbVie Prepares To Launch, Some Wind Gets Knocked Out Of Its Sails


Related Companies




Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts